Using X-ray Velocimetry to measure lung function and assess the efficacy of a Pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis
Mutation-independent cystic fibrosis treatment by opening calcium-activated chloride channel with a novel GPR39 agonist, DS-1039